Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mucosa-associated Lymphoid Tissue Lymphoma (MALT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00547196
What this trial is testing

AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
City of Hope Medical Center 10
Early research (Phase 1)Study completedNCT00002980
What this trial is testing

Decitabine in Treating Patients With Melanoma or Other Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
California Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT04172246
What this trial is testing

Study of Zanubrutinib in Japanese Participants With B-Cell Malignancies

Who this might be right for
Mature B-cell Malignancies
BeiGene 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115
What this trial is testing

Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
City of Hope Medical Center 260
Testing effectiveness (Phase 2)Ended earlyNCT00337259
What this trial is testing

Gemcitabine for Marginal Zone Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaMarginal Zone Lymphoma
Asan Medical Center 43
Testing effectiveness (Phase 2)Study completedNCT04465162
What this trial is testing

Radiation Therapy Alone for the Treatment of Stage 1 and 2 Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

Who this might be right for
Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueAnn Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueExtranodal Marginal Zone Lymphoma
M.D. Anderson Cancer Center 75
Early research (Phase 1)Looking for participantsNCT06026319
What this trial is testing

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

Who this might be right for
Non-hodgkin LymphomaRelapsed Non-Hodgkin LymphomaRefractory Non-Hodgkin Lymphoma+7 more
Marcela V. Maus, M.D.,Ph.D. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07638722
What this trial is testing

Testing Mosunetuzumab Alone, With Zanubrutinib, or With Polatuzumab Vedotin for Treating Marginal Zone Lymphoma That Came Back or Didn't Get Better With Treatment

Who this might be right for
Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueRecurrent Nodal Marginal Zone LymphomaRecurrent Splenic Marginal Zone Lymphoma+3 more
SWOG Cancer Research Network
Testing effectiveness (Phase 2)UnknownNCT00377195
What this trial is testing

Involved Field Radiotherapy for Non-gastric Marginal Zone Lymphoma

Who this might be right for
Non-gastric Marginal Zone Lymphoma
Trans Tasman Radiation Oncology Group 79
Large-scale testing (Phase 3)WithdrawnNCT04796922
What this trial is testing

To Evaluate Efficacy and Safety of Parsaclisib Plus Either Rituximab or Obinutuzumab in R/R Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) (CITADEL-302)

Who this might be right for
Follicular Lymphoma ( FL)Marginal Zone Lymphoma (MZL)
Incyte Corporation
Testing effectiveness (Phase 2)Study completedNCT00253630
What this trial is testing

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Who this might be right for
Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueNodal Marginal Zone LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT00210353
What this trial is testing

Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma

Who this might be right for
Lymphoma, Mucosa-Associated Lymphoid Tissue
International Extranodal Lymphoma Study Group (IELSG) 454
Not applicableStudy completedNCT00712556
What this trial is testing

PET Study in Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Looking for participantsNCT06563505
What this trial is testing

Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Not applicableStudy completedNCT00274794
What this trial is testing

VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL

Who this might be right for
Lymphoma
The Cleveland Clinic 55
Testing effectiveness (Phase 2)Active Not RecruitingNCT02339922
What this trial is testing

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaFollicular LymphomaLymphoplasmacytic Lymphoma+6 more
University of Washington 33
Early research (Phase 1)Study completedNCT00003970
What this trial is testing

Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
AIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00117156
What this trial is testing

Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinMALT Lymphoma
Dana-Farber Cancer Institute 26
Next Page
138